EWTX NASDAQ
Edgewise Therapeutics, Inc.
1W: -3.9%
1M: +1.6%
3M: +11.5%
YTD: +37.6%
1Y: +119.8%
3Y: +249.2%
5Y: +18.0%
$32.70
+0.01 (+0.03%)
Weekly Expected Move ±11.8%
$25
$29
$33
$37
$41
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026243
Institutions Holding
+18 vs prior
88.3%
Ownership
-3.84%
42
New
57
Increased
109
Reduced
53
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-05 | Donovan Joanne M. | officer: cmo | S-Sale | 50,000 | $38.57 | $1.9M | Filing |
| 2026-05-04 | Donovan Joanne M. | officer: cmo | S-Sale | 5,230 | $31.29 | $164K | Filing |
| 2026-04-01 | Fox Jonathan C | director | A-Grant/Award | 339 | $— | $0 | Filing |
| 2026-04-01 | Donovan Joanne M. | officer: cmo | S-Sale | 28,662 | $32.31 | $926K | Filing |
| 2026-03-31 | Donovan Joanne M. | officer: cmo | S-Sale | 21,338 | $32.12 | $685K | Filing |
| 2026-01-21 | Edris Badreddin | director | S-Sale | 66,477 | $29.44 | $2.0M | Filing |
| 2026-01-21 | Edris Badreddin | director | S-Sale | 10,463 | $29.44 | $308K | Filing |
| 2026-01-21 | Edris Badreddin | director | S-Sale | 7,605 | $29.44 | $224K | Filing |
| 2026-01-21 | Edris Badreddin | director | S-Sale | 17,236 | $29.44 | $507K | Filing |
| 2026-01-21 | Edris Badreddin | director | S-Sale | 13,690 | $29.44 | $403K | Filing |
| 2026-01-02 | Fox Jonathan C | director | A-Grant/Award | 473 | $— | $0 | Filing |
| 2025-11-12 | Russell Alan J | officer: chief scientific officer | S-Sale | 100,000 | $21.12 | $2.1M | Filing |
| 2025-11-11 | Fox Jonathan C | director | P-Purchase | 10,700 | $18.64 | $199K | Filing |
| 2025-10-01 | Fox Jonathan C | director | A-Grant/Award | 728 | $— | $0 | Filing |
| 2025-08-26 | Russell Alan J | officer: chief scientific officer | S-Sale | 100,000 | $14.60 | $1.5M | Filing |
| 2025-08-12 | MOORE JOHN R | officer: general counsel | S-Sale | 2,098 | $13.39 | $28K | Filing |
| 2025-08-12 | Russell Alan J | officer: chief scientific officer | S-Sale | 1,907 | $13.39 | $26K | Filing |
| 2025-08-12 | KOCH KEVIN | officer: president and ceo | S-Sale | 7,972 | $13.39 | $107K | Filing |
| 2025-08-12 | Donovan Joanne M. | officer: cmo | S-Sale | 2,862 | $13.39 | $38K | Filing |
| 2025-08-12 | Derakhshan Behrad | officer: chief business officer | S-Sale | 2,491 | $13.39 | $33K | Filing |
| 2025-08-12 | Carruthers R Michael | officer: chief financial officer | S-Sale | 1,428 | $13.39 | $19K | Filing |
| 2025-07-01 | Fox Jonathan C | director | A-Grant/Award | 858 | $— | $0 | Filing |
| 2025-05-02 | Russell Alan J | officer: chief scientific officer | S-Sale | 1,551 | $16.45 | $26K | Filing |
| 2025-05-02 | MOORE JOHN R | officer: general counsel | S-Sale | 1,930 | $16.45 | $32K | Filing |
| 2025-05-02 | Derakhshan Behrad | officer: chief business officer | S-Sale | 1,691 | $16.45 | $28K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 15,518,492 | $489M | — | 2026-03-31 | Filing |
| RA CAPITAL MANAGEMENT, L.P. | 10,428,437 | $328M | — | 2026-03-31 | Filing |
| Lion Point Capital, LP | 9,100 | $287M | — | 2026-03-31 | Filing |
| Paradigm Biocapital Advisors LP | 7,365,038 | $232M | +823,828 | 2026-03-31 | Filing |
| BlackRock, Inc. | 6,472,991 | $204M | -157,585 | 2026-03-31 | Filing |
| JANUS HENDERSON GROUP PLC | 5,915,556 | $186M | +1,348,706 | 2026-03-31 | Filing |
| Driehaus Capital Management LLC | 4,477,942 | $141M | +286,749 | 2026-03-31 | Filing |
| Siren, L.L.C. | 4,430,263 | $140M | -99,727 | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,788,161 | $119M | +3,788,161 | 2026-03-31 | Filing |
| Cormorant Asset Management, LP | 3,260,000 | $103M | -25,000 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,789,819 | $56M | +43,597 | 2026-03-31 | Filing |
| STATE STREET CORP | 1,716,823 | $54M | -520 | 2026-03-31 | Filing |
| Integral Health Asset Management, LLC | 1,600,000 | $50M | +100,000 | 2026-03-31 | Filing |
| Soleus Capital Management, L.P. | 1,449,915 | $46M | +539,915 | 2026-03-31 | Filing |
| BANK OF AMERICA CORP /DE | 1,327,360 | $42M | -147,437 | 2026-03-31 | Filing |
| UBS Group AG | 1,311,125 | $41M | -805,948 | 2026-03-31 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 1,219,717 | $38M | +6,060 | 2026-03-31 | Filing |
| AMERICAN CENTURY COMPANIES INC | 1,147,176 | $36M | -39,291 | 2026-03-31 | Filing |
| FMR LLC | 1,017,052 | $32M | +324,097 | 2026-03-31 | Filing |
| First Light Asset Management, LLC | 1,001,846 | $32M | -571,855 | 2026-03-31 | Filing |